| 6461 Stock | | | TWD 24.45 0.30 1.24% |
Intech Biopharm market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Intech Biopharm or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
Intech Biopharm has current Market Risk Adjusted Performance of
(0.68).
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | (0.68) | |
| ER[a] | = | Expected return on investing in Intech Biopharm |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Intech Biopharm Market Risk Adjusted Performance Peers Comparison
Intech Market Risk Adjusted Performance Relative To Other Indicators
Intech Biopharm is rated
below average in market risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.